Merck to Acquire Schering-Plough

It looks like Merck will be acquiring Schering-Plough in a $41.1 billion deal. But wait, it's a bit confusing. People are referring to this as a "reverse merger" and Merck's top executive, Chairman and CEO Richard Clarke, will lead the combined company, but Schering-Plough will be the surviving public corporation. The new company will be called Merck.